| Product NDC: | 65977-5033 |
| Proprietary Name: | Methocarbamol |
| Non Proprietary Name: | Methocarbamol |
| Active Ingredient(s): | 500 mg/1 & nbsp; Methocarbamol |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 65977-5033 |
| Labeler Name: | Hetero Drugs Limited Unit III |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA090200 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20091106 |
| Package NDC: | 65977-5033-3 |
| Package Description: | 500 TABLET in 1 BOTTLE (65977-5033-3) |
| NDC Code | 65977-5033-3 |
| Proprietary Name | Methocarbamol |
| Package Description | 500 TABLET in 1 BOTTLE (65977-5033-3) |
| Product NDC | 65977-5033 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Methocarbamol |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20091106 |
| Marketing Category Name | ANDA |
| Labeler Name | Hetero Drugs Limited Unit III |
| Substance Name | METHOCARBAMOL |
| Strength Number | 500 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Centrally-mediated Muscle Relaxation [PE],Muscle Relaxant [EPC] |